Dysnatremias in cancer

Mar 16, 2020 by in NEPHROLOGY Comments Off on Dysnatremias in cancer

Hyponatremia Hyponatremia and cancer relationship Hyponatremia is the most common electrolyte abnormality observed in cancer patients. In a retrospective cohort study from a comprehensive cancer center, hyponatremia (serum Na +…

read more

Calcium and phosphorus disorders

Mar 16, 2020 by in NEPHROLOGY Comments Off on Calcium and phosphorus disorders

Introduction Disturbances in calcium and phosphorus homeostasis are commonly encountered when caring for cancer patients. These may result from the malignancy itself or as a complication of the treatment process….

read more

Potassium disorders

Mar 16, 2020 by in NEPHROLOGY Comments Off on Potassium disorders

Introduction Potassium abnormalities, both hypo- and hyperkalemia, can occur with significant consequences in patients with malignancies. In addition to typical causes of disturbances in potassium homeostasis, there are unique etiologies…

read more

Fibrillary and immunotactoid glomerulonephritis

Mar 16, 2020 by in NEPHROLOGY Comments Off on Fibrillary and immunotactoid glomerulonephritis

Fibrillary glomerulonephritis Overview and epidemiology Fibrillary glomerulonephritis (FGN) was first described in 1977. It is a rare disease, with incidence of less than 1% of native kidney biopsies. It is…

read more

Systemic light chain amyloidosis

Mar 16, 2020 by in NEPHROLOGY Comments Off on Systemic light chain amyloidosis

Introduction Systemic amyloidoses encompass a group of diseases characterized by deposition of abnormal, insoluble, misfolded, β-pleated protein fibrils in different organs. Amyloid protein positively stains with Congo red and demonstrates…

read more

Sinusoidal obstruction syndrome

Mar 16, 2020 by in NEPHROLOGY Comments Off on Sinusoidal obstruction syndrome

Introduction Sinusoidal obstruction syndrome (SOS) is a well-described complication of the high-dose conditioning regimens used in hematopoietic stem cell transplantation (HSCT), as well as certain hepatotoxic chemotherapies or radiation therapy…

read more

Monoclonal immunoglobulin deposition disease

Mar 16, 2020 by in NEPHROLOGY Comments Off on Monoclonal immunoglobulin deposition disease

Introduction Monoclonal immunoglobulin deposition disease (MIDD) is characterized by the deposition of monoclonal light and/or heavy chains within glomerular, tubular, and vessel wall basement membranes. Three subtypes of MIDD have…

read more

Hematopoietic cell transplant associated kidney injury

Mar 16, 2020 by in NEPHROLOGY Comments Off on Hematopoietic cell transplant associated kidney injury

Key wordsKidney, hematopoietic cell transplant, graft-versus-host disease, transplant-associated thrombotic microangiopathy   Kidney injury in graft versus host disease Introduction Hematopoietic cell transplant (HCT) is a commonly used procedure to treat…

read more

Cast nephropathy

Mar 16, 2020 by in NEPHROLOGY Comments Off on Cast nephropathy

Introduction Acute kidney injury (AKI) remains a common presentation of multiple myeloma (MM). Depending on the definition of AKI used, between 18% and 56% of patients with MM are affected….

read more

Paraproteins

Mar 16, 2020 by in NEPHROLOGY Comments Off on Paraproteins

Introduction This section of the book focuses on paraprotein-related kidney disorders. In this chapter, we describe a general overview of paraproteins and their adverse effects on the kidneys with emphasis…

read more
Get Clinical Tree app for offline access